Inventor · disambiguated record
Mark Litton
Also filed as: LITTON MARK · LITTON MARK J
20 granted patents·6 pending applications·297 citations·filing 2004–2020
96Inventor score
Files withALDERBIO HOLDINGS LLC14CREGG JAMES M3SMITH JEFFREY T L3KECK GRADUATE INST2ALDER BIOPHARMACEUTICALS INC1
Top patents by PatentIndex Score
26 records- 0198US8337847B2Methods of treating anemia using anti-IL-6 antibodiesSMITH JEFFREY T L·Filed 2009·Granted Dec 25, 2012·48 cites·35 claims
- 0298US7906117B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2008·Granted Mar 15, 2011·55 cites·23 claims
- 0397US7927863B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyALDER BIOPHARMACEUTICALS INC·Filed 2006·Granted Apr 19, 2011·38 cites·28 claims
- 0495US9452227B2Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragmentsGARCIA-MARTINEZ LEON·Filed 2009·Granted Sep 27, 2016·27 cites·21 claims
- 0595US8268582B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyCREGG JAMES M·Filed 2004·Granted Sep 18, 2012·51 cites·31 claims
- 0693US10053506B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2015·Granted Aug 21, 2018·9 cites·14 claims
- 0793US9821057B2Anti-IL-6 antibody for use in the treatment of cachexiaALDERBIO HOLDINGS LLC·Filed 2015·Granted Nov 21, 2017·9 cites·1 claims
- 0893US9724410B2Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicitySMITH JEFFREY T L·Filed 2010·Granted Aug 8, 2017·13 cites·25 claims
- 0993US9187560B2Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2012·Granted Nov 17, 2015·8 cites·19 claims
- 1092US10640560B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or feverALDERBIO HOLDINGS LLC·Filed 2018·Granted May 5, 2020·3 cites·12 claims
- 1191US10160804B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2016·Granted Dec 25, 2018·6 cites·15 claims
- 1289US10391169B2Method of treating allergic asthma with antibodies to IL-6ALDERBIO HOLDINGS LLC·Filed 2017·Granted Aug 27, 2019·4 cites·10 claims
- 1387US9546213B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverSMITH JEFFREY T L·Filed 2011·Granted Jan 17, 2017·7 cites·12 claims
- 1487US8709756B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyCREGG JAMES M·Filed 2012·Granted Apr 29, 2014·4 cites·23 claims
- 1586US10117955B2Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodiesALDERBIO HOLDINGS LLC·Filed 2016·Granted Nov 6, 2018·3 cites·19 claims
- 1685US9775921B2Subcutaneously administrable composition containing anti-IL-6 antibodyGARCIA-MARTINEZ LEON F·Filed 2010·Granted Oct 3, 2017·9 cites·14 claims
- 1778US9873746B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyCREGG JAMES M·Filed 2011·Granted Jan 23, 2018·1 cites·8 claims
- 1876US10259883B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyKECK GRADUATE INST·Filed 2015·Granted Apr 16, 2019·1 cites·17 claims
- 1975US10155819B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyALDERBIO HOLDINGS LLC·Filed 2014·Granted Dec 18, 2018·1 cites·21 claims
- 2073US11447560B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyKECK GRADUATE INST·Filed 2019·Granted Sep 20, 2022·0 cites·23 claims
- 2171US2020108140A1Antibodies to il-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 2271US2020354446A1Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and /or feverALDERBIO HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2370US2021107975A1Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2467US2018117149A1Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2017·Application pending·0 cites
- 2558US2019270805A1Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDING LLC·Filed 2018·Application pending·0 cites
- 2650US2019083665A1Antibodies to il-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Litton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →